zingerone has been researched along with Fibrosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Thubiani, WS; Azhar, AS; Banjar, ZM; El-Bassossy, HM; Elberry, AA; Ghareib, SA; Mujallid, MI; Watson, ML | 1 |
| Cai, ZL; Deng, W; Duan, MX; Liu, C; Tang, QZ; Wu, QQ; Xie, QW; Xie, SY; Yuan, Y | 1 |
2 other study(ies) available for zingerone and Fibrosis
| Article | Year |
|---|---|
Zingerone alleviates the delayed ventricular repolarization and AV conduction in diabetes: Effect on cardiac fibrosis and inflammation.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Electrocardiography; Fibrosis; Guaiacol; Heart Conduction System; Heart Ventricles; Inflammation; Lipids; Male; Oxidative Stress; Rats; Rats, Wistar; Weight Gain | 2017 |
Zingerone attenuates aortic banding-induced cardiac remodelling via activating the eNOS/Nrf2 pathway.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Aorta; Cardiomegaly; Cells, Cultured; Fibrosis; Guaiacol; Heart Failure; Inflammation; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Myocytes, Cardiac; NF-E2-Related Factor 2; Nitric Oxide Synthase Type III; Oxidative Stress; Phenylephrine; Rats; Signal Transduction; Ventricular Remodeling | 2019 |